Table 2 Prevalence (n (%)) of COPD and CAO by age groups, sex, area and among all subjects
From: Decreased COPD prevalence in Sweden after decades of decrease in smoking
Age groups | Sex | Area | All | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
< 40 years | 41–60 years | > 60 years | |||||||||
Women | Men | Women | Men | Women | Men | Women | Men | Western Sweden | Northern Sweden | ||
n = 257 | n = 202 | n = 438 | n = 356 | n = 273 | n = 313 | n = 968 | n = 871 | n = 1148 | n = 691 | n = 1839 | |
CAO: FEV1/FVC < 0.7 | 5 (1.9) | 8 (4.0) | 23 (5.3) | 26 (7.3) | 45 (16.5) | 53 (16.9) | 73 (7.5) | 87 (10.0) | 93 (8.4) | 64 (9.3) | 160 (8.7) |
CAO: FEV1/FVC < 0.7 & FEV1 < 80% | 1 (0.4) | 1 (0.5) | 6 (1.4) | 15 (4.2) | 23 (8.4) | 26 (8.3) | 30 (3.1) | 42 (4.8) | 42 (3.7) | 30 (4.3) | 72 (3.9) |
COPD: FEV1/FVC < 0.7 | 4 (1.6) | 6 (3.0) | 18 (4.1) | 25 (7.0) | 34 (12.5) | 41 (13.1) | 56 (5.8) | 73 (8.3) | 74 (6.4) | 54 (7.8) | 128 (7.0) |
COPD: FEV1/FVC < 0.7 & FEV1 < 80% | 1 (0.4) | 1 (0.5) | 5 (1.1) | 15 (4.2) | 19 (7.0) | 24 (7.7) | 25 (2.6) | 40 (4.6) | 38 (3.3) | 27 (3.9) | 65 (3.5) |